IPXXW Inflection Point Acquisition Corporation II

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): November 13, 2024 (November 12, 2024)

 

Inflection Point Acquisition Corp. II

(Exact name of registrant as specified in its charter)

 

Cayman Islands		001-41711		N/A
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

 

167 Madison Avenue Suite 205 #1017

New York, New York 10016

(Address of principal executive offices, including zip code)

 

Registrant’s telephone number, including area code: (212) 476-6908

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☒	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one redeemable warrant		IPXXU		The Nasdaq Stock Market LLC
Class A ordinary shares, par value $0.0001 per share		IPXX		The Nasdaq Stock Market LLC
Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share		IPXXW		The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 1.01 Entry into a Material Definitive Agreement

 

Amendment No. 1 to Business Combination Agreement

 

As previously disclosed, on August 21, 2024, Inflection Point Acquisition Corp. II, a Cayman Islands exempted company (“Inflection Point”), USA Rare Earth, LLC, a Delaware limited liability company (“USARE”) and IPXX Merger Sub, LLC, a Delaware limited liability company and a direct wholly owned subsidiary of Inflection Point (“Merger Sub”) entered into a Business Combination Agreement (as it may be amended, supplemented or otherwise modified from time to time in accordance with its terms, the “Business Combination Agreement” and the transactions contemplated thereby, collectively, the “Business Combination”). In connection with the Business Combination, Inflection Point will be renamed “USA Rare Earth, Inc.” (“New USARE”).

 

Also as previously disclosed, on August 21, 2024, USARE and certain accredited investors, including certain funds related to Inflection Point (the “Class A Convertible Preferred Unit Investors”) entered into Securities Purchase Agreements (the “Class A Convertible Preferred SPAs”). Pursuant to the Class A Convertible Preferred SPAs, the Class A Convertible Preferred Unit Investors purchased (i) Class A-1 convertible preferred unit of USARE or Class A-2 convertible preferred unit of USARE and (ii) warrants to purchase Class A units of USARE (“USARE Class A Units”) at $12.00 per USARE Class A Unit (each such warrant, a “USARE Class A Preferred Investor Warrant”), for an aggregate purchase price of approximately $25 million.

 

On November 12, 2024, Inflection Point and USARE entered into that certain Amendment No. 1 to the Business Combination Agreement (the “BCA Amendment”). The BCA Amendment:

 

(i)

amends Section 2.02(b) and Section 2.03(b)(iii) to provide that in connection with the Business Combination, each USARE Class A Preferred Investor Warrant shall be cancelled and converted into the right to receive a Domesticated Purchaser Series A Preferred Investor Warrant (as defined in the Business Combination Agreement) exercisable for a number of shares of common stock of New USARE equal to the aggregate number of Class A units of USARE that would be issued upon full exercise of such USARE Class A Preferred Investor Warrant; and

 

(ii)

amends Article X to define the term “Expiration Time” with respect to the Member Support Agreement (as defined in the Business Combination Agreement) to mean the earlier of the closing of the Business Combination or the termination of the Business Combination Agreement.

 

No other changes were made to the Business Combination Agreement. The foregoing description of the BCA Amendment does not purport to be complete and is qualified in its entirety by the terms and conditions of the BCA Amendment, a copy of which is filed as Exhibit 2.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

Non-Redemption Agreement

 

As previously disclosed, Inflection Point has called an extraordinary general meeting of the Company to be held at 11:00 a.m. Eastern Time on November 18, 2024 (the “Meeting”) for the purpose of considering and voting on, among other proposals, a proposal to approve, by way of special resolution, an amendment to Inflection Point’s Amended and Restated Memorandum and Articles of Association (the “Articles”) to extend the date by which Inflection Point has to consummate a business combination (the “Extension”) from November 30, 2024 to August 21, 2025 (such earlier time as the directors may approve or such later time as the shareholders may approve in accordance with the Articles (the “Articles Extension Proposal”).

 

 

On November 13, 2024, Inflection Point and Newtyn Partners, LP and Newtyn TE Partners, LP (collectively, “Newtyn”), entered into a non-redemption agreement (the “Non-Redemption Agreement”). Pursuant to the Non-Redemption Agreement, Newtyn agreed not to redeem (or to validly rescind any redemption requests with respect to) an aggregate of 700,000 publicly-held Class A ordinary shares of Inflection Point (“Non-Redeemed Shares”) in connection with the shareholder vote on the Articles Extension Proposal. In exchange for the foregoing commitment not to redeem the Non-Redeemed Shares, Inflection Point granted Newtyn an option to enter into a forward purchase agreement (the “Forward Purchase Agreement”) in connection with the closing of the Business Combination (the “Forward Purchase Option”) with respect to up to 700,000 Class A ordinary shares of Inflection Point. Pursuant to the Forward Purchase Option, Newtyn will have the right, but not the obligation, to enter into an over-the-counter Equity Prepaid Forward Transaction (a “Forward Purchase Transaction”) with respect to up to 700,000 Class A ordinary shares of Inflection Point in connection with the closing of the Business Combination.

 

The Forward Purchase Agreement would provide that no later than the earlier of (a) one business day after the closing of the Business Combination and (b) the date any assets from Inflection Point’s trust account are disbursed in connection with the Business Combination, an amount (the “Prepayment Amount”) equal to the product of (i) an amount (the “Initial Price”) equal to the redemption price per share payable to investors who elected to redeem in connection with the Business Combination and (ii) the number of Class A ordinary shares subject to the Forward Purchase Transaction (the “FPA Shares”) would be deposited into an escrow account from the cash held in Inflection Point’s trust account. The Prepayment Amount will be invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act of 1940, as amended, which invest only in direct U.S. government treasury obligations.

 

The Forward Purchase Agreement’s maturity date would be the date 90 days after the closing of the Business Combination (the “Maturity Date”). Upon the occurrence of the Maturity Date, in exchange for delivery of the FPA Shares then-subject to the Forward Purchase Transaction, New USARE would pay Newtyn an amount (the “Maturity Consideration”) equal to the amount then on deposit in the escrow account, including accrued interest. The Maturity Consideration would be released to Newtyn from the escrow account.

 

From time to time on any day Nasdaq is open for trading following the date of the closing of the Business Combination (any such date, an “OET Date”), Newtyn would be able to, in its absolute discretion, terminate its Forward Purchase Agreement in whole or in part with respect to any number of FPA Shares by giving notice of such termination and the specified number of FPA Shares (such quantity, the “Terminated Shares”). An amount equal to the product of (i) the quotient of (a) the Terminated Shares divided by (b) the FPA Shares, multiplied by (ii) the value of the escrow account, including accrued interest, at such OET Date would be released to New USARE from the escrow account.

 

The Forward Purchase Agreement will include customary representations, warranties, covenants and events of default for a transaction of its type and size.

 

The foregoing summary of the Non-Redemption Agreement and the potential Forward Purchase Agreement is qualified in its entirety by reference to the text of the Non-Redemption Agreement, which is filed as Exhibit 10.1 hereto and is incorporated herein by reference.

 

 

Additional Information about the Business Combination and Where to Find it

 

The Business Combination will be submitted to the shareholders of Inflection Point for their consideration. Inflection Point and USARE have filed a registration statement on Form S-4 (the “Registration Statement”) with the SEC, which includes a proxy statement/prospectus and certain other related documents, which will be both the proxy statement to be distributed to Inflection Point’s shareholders in connection with Inflection Point’s solicitation for proxies for the vote by Inflection Point’s shareholders in connection with the Business Combination and other matters to be described in the Registration Statement, as well as the prospectus relating to the offer and sale of the securities to be issued (or deemed issued) to Inflection Point’s shareholders and USARE’s equityholders in connection with the completion of the Business Combination. After the Registration Statement is declared effective, Inflection Point will mail a definitive proxy statement and other relevant documents to its shareholders as of the record date established for voting on the Business Combination. Inflection Point’s shareholders and other interested persons are advised to read the Registration Statement, the preliminary proxy statement/prospectus included in the Registration Statement and any amendments thereto and, once available, the definitive proxy statement/prospectus and documents incorporated by reference therein filed in connection with the Business Combination, in connection with Inflection Point’s solicitation of proxies for its extraordinary general meeting to be held to approve, among other things, the Business Combination, as well as other documents filed with the SEC in connection with the Business Combination, as these documents will contain important information about Inflection Point, USARE, and the Business Combination. Shareholders of Inflection Point and members of USARE may obtain a copy of the preliminary or definitive proxy statement/prospectus, once available, as well as other documents filed by Inflection Point with the SEC that will or may be incorporated by reference in the proxy statement/prospectus, without charge, at the SEC’s website located at www.sec.gov or by directing a written request to Inflection Point at Inflection Point Acquisition Corp. II, 167 Madison Avenue Suite 205 #1017 New York, New York 10016.

 

Participants in the Solicitation

 

Inflection Point and its directors and executive officers may be deemed participants in the solicitation of proxies from Inflection Point’s stockholders with respect to the Business Combination. A list of the names of those directors and executive officers and a description of their interests in Inflection Point is contained in the Registration Statement in the section entitled “The Business Combination — Interests of Certain Inflection Point Persons in the Business Combination” which is available free of charge at the SEC’s website at www.sec.gov and at the following URL: https://www.sec.gov/Archives/edgar/data/1787434/000121390024096943/ea0220524-01.htm.

 

USARE’s directors and executive officers may also be deemed to be participants in the solicitation of proxies from the stockholders of Inflection Point in connection with the Business Combination. A list of the names of such directors and executive officers and information regarding their interests in the Business Combination is included in the Registration Statement in the section entitled “The Business Combination — Interests of the USARE Managers and Executive Officers” at the SEC’s website at www.sec.gov and at the following URL: https://www.sec.gov/Archives/edgar/data/1787434/000121390024096943/ea0220524-01.htm. 

 

Forward-Looking Statements

 

This Current Report on Form 8-K includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements include, without limitation, statements regarding or similar to: estimates and forecasts of financial and operational metrics; plans, goals, ambitions, targets, future business and operations, and projections regarding future mining capabilities, operations, reserves, manufacturing capacity and plant performance; projections of market opportunity and market share; estimates and projections of adjacent industry sector opportunities; USARE’s commercialization costs and timeline; USARE’s ability to timely and effectively meet construction and mining timelines and scale its production and manufacturing processes; USARE’s ability to maintain, protect, and enhance its intellectual property; development of favorable regulations and government demand, contracts, and incentives affecting the markets in which USARE operates; USARE’s ability to receive and/or maintain the necessary permits and other government approvals necessary to operate its business; the estimates with respect to the rare earth and critical element and mineral deposits in the Round Top deposit; Inflection Point’s and USARE’s expectations with respect to future performance of USARE’s (and, after the Business Combination, the combined company’s) business; the expected funding of the PIPE Investment and pre-funded investment, to the extent they remain unfunded; anticipated financial impacts of the Business Combination; Inflection Point’s ability to obtain an extension of its deadline to complete an initial business combination; the satisfaction of the closing conditions to the Business Combination; and the timing of the completion of the Business Combination. For example, projections of future enterprise value, revenue, market share, and other metrics are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “anticipate,” “believe,” “continue” “estimate,” “expect,” “intend,” “may,” “potential,” “predict,” “should,” or “will,” or the negatives of these terms or variations of them or similar terminology, although not all forward-looking statements contain such identifying words.

 

 

These forward-looking statements are based upon estimates and assumptions that, while considered reasonable by Inflection Point, USARE and their respective managements, as the case may be, are inherently uncertain. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction, or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of Inflection Point and USARE. Such forward-looking statements are subject to risks, uncertainties, and other factors which could cause actual results to differ materially from those expressed or implied by such forward-looking statements. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: (1) changes in domestic and foreign business, market, financial, political conditions, and in applicable laws and regulations, (2) the occurrence of any event, change or other circumstances that could give rise to the termination definitive agreements and any negotiations with respect to the Business Combination; (3) the outcome of any legal proceedings that may be instituted against Inflection Point, USARE, the combined company, or others; (4) the inability to complete the Business Combination due to the failure to obtain approval of the shareholders of Inflection Point to extend the deadline for Inflection Point to complete an initial business combination, for the Business Combination or to satisfy other conditions to closing; (5) changes to the proposed structure of the Business Combination that may be required or appropriate as a result of applicable laws or regulations; (6) the ability to meet stock exchange listing standards following the consummation of the Business Combination; (7) the risk that the Business Combination disrupts current plans and operations of Inflection Point or USARE as a result of the announcement and consummation of the Business Combination; (8) the ability to recognize the anticipated benefits of the Business Combination, which may be affected by, among other things: competition, the ability of the combined company to grow and manage growth profitably, the ability of the combined company to build or maintain relationships with customers and suppliers and retain its management and key employees, the supply and demand for rare earth minerals, the timing and amount of future production, costs of production, capital expenditures and requirements for additional capital, timing of future cash flow provided by operating activities, if any, uncertainty in any mineral resource estimates, uncertainty in any geological, metallurgical, and geotechnical studies and opinions, and transportation risks; (9) costs related to the Business Combination; (10) the possibility that USARE or the combined company may be adversely affected by other economic, business, and/or competitive factors; (11) estimates of expenses and profitability and underlying assumptions with respect to stockholder redemptions and purchase price and other adjustments; and (12) other risks and uncertainties set forth in the section entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in the Registration Statement and in Inflection Point’s final prospectus relating to its initial public offering dated May 24, 2023, and in subsequent Inflection Point filings with the SEC relating to the Business Combination expected to be filed by Inflection Point, and periodic Exchange Act reports filed with the SEC such as its Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K.

 

You should carefully consider the foregoing risk factors and the other risks and uncertainties which will be more fully described in the “Risk Factors” section of the Registration Statement and other documents filed by Inflection Point from time to time with the SEC. If any of these risks materialize or USARE’s assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that neither Inflection Point nor USARE presently know or that they currently believe are immaterial that could also cause actual results to differ from contained in the forward-looking statements. In addition, forward-looking statements reflect Inflection Point and USARE’s expectations, plans, or forecasts of future events and views as of the date of this Current Report on Form 8-K. Nothing in this communication should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. These forward-looking statements speak only as of the date of this Current Report on Form 8-K. Inflection Point, USARE, and their respective representatives and affiliates specifically disclaim any obligation to, and do not intend to, update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Accordingly, these forward-looking statements should not be relied upon as representing Inflection Point’s, USARE’s, or any of their respective representatives or affiliates’ assessments as of any date subsequent to the date of this Current Report on Form 8-K, and therefore undue reliance should not be placed upon the forward-looking statements. This Current Report on Form 8-K contains preliminary information only, is subject to change at any time, and is not, and should not be assumed to be, complete or constitute all of the information necessary to adequately make an informed decision regarding any potential investment in connection with the Business Combination. 

 

No Offer or Solicitation

 

This Current Report on Form 8-K and the exhibits hereto do not constitute an offer to sell or exchange, or a solicitation of an offer to buy or exchange, or a recommendation to purchase, any securities in any jurisdiction, or the solicitation of any proxy, vote, consent or approval in any jurisdiction with respect to any securities or in connection with the Business Combination. There shall not be any offer, sale or exchange of any securities of USARE or Inflection Point in any jurisdiction where, or to any person to whom, such offer, sale or exchange may be unlawful under the laws of such jurisdiction prior to registration or qualification under the securities laws of any such jurisdiction.

 

 

Item 9.01 Financial Statements and Exhibits

 

(d) Exhibits. The following exhibits are filed or furnished with this Current Report on Form 8-K:

 

Exhibit Number		Description
2.1†		Amendment No. 1 to Business Combination Agreement, dated as of November 12, 2024, by and between Inflection Point Acquisition Corp. II and USA Rare Earth, LLC.
10.1		Non-Redemption Agreement, dated as of November 12, 2024, by and among Inflection Point Acquisition Corp. II and Newtyn Partners, LP and Newtyn TE Partners, LP.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

	INFLECTION POINT ACQUISITION CORP. II
Date: November 13, 2024	By:	/s/ Michael Blitzer
	Name:	Michael Blitzer
	Title:	Chairman and Chief Executive Officer
		(Principal Executive Officer)

 

 

6

 

Exhibit 2.1

 

AMENDMENT NO. 1

TO

BUSINESS COMBINATION AGREEMENT

 

This AMENDMENT is made and entered into as of November 12, 2024 (this “Amendment”), by and between Inflection Point Acquisition Corp. II, a Cayman Islands exempted company (the “Purchaser”) and USA Rare Earth, LLC, a Delaware limited liability company (the “Company”). Each of the foregoing will individually be referred to herein as a “Party” and, collectively as the “Parties”. Capitalized terms used, but not otherwise defined, herein shall have the respective meanings assigned to such terms in the Agreement (as defined below).

 

RECITALS:

 

WHEREAS, the Parties and IPXX Merger Sub, LLC, a Delaware limited liability company and a direct wholly owned subsidiary of the Purchaser entered into that certain Business Combination Agreement, dated as of August 21, 2024 (as amended from time to time in accordance with its terms, the “Agreement”);

 

WHEREAS, pursuant to Section 9.10 of the Agreement, the Agreement may be amended by the Parties at any time by execution of an instrument in writing signed on behalf of each of the Parties; and

 

WHEREAS, the Parties desire to amend the Agreement as set forth herein.

 

NOW, THEREFORE, in consideration of the covenants, promises and the representations and warranties set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:

 

1. Amendment to Section 2.02(b). Section 2.02(b) of the Agreement is hereby amended and restated in its entirety to read as follows:

 

(b) Company Class A Preferred Investor Warrants. The consideration to be paid in, or in connection with, the Merger to a holder in respect to each Company Class A-1 Preferred Investor Warrants or Company Class A-2 Preferred Investor Warrants shall be such number of Domesticated Purchaser Series A Investor Warrant(s) eligible to purchase a number of shares of Domesticated Purchaser Common Stock equal to the number of Company Class A Units that would be issued upon full exercise of such Company Class A-1 Preferred Investor Warrants or Company Class A-2 Preferred Investor Warrants immediately prior to the Effective Time (the “Class A Preferred Investor Warrant Consideration”).

 

2. Amendment to Section 2.03(b)(ii). Section 2.03(b)(ii) of the Agreement is hereby amended and restated in its entirety to read as follows:

 

(ii) each Company Class A-1 Preferred Investor Warrant and Company Class A-2 Preferred Investor Warrant shall be cancelled and converted into the right to receive a Domesticated Purchaser Series A Investor Warrant exercisable for a number of shares of Domesticated Purchaser Common Stock equal to the aggregate number of Company Class A Units that would be issued upon full exercise of such Company Class A-1 Preferred Investor Warrants or Company Class A-2 Preferred Investor Warrant.

 

 

3. Amendment to Article X. Article X “Definitions” of the Agreement is hereby amended by adding the following defined term:

 

“Expiration Time” means, with respect to the Member Support Agreement, the earlier of the Closing or the termination of this Agreement in accordance with its terms.

 

4. Counterparts; Electronic Delivery. This Amendment may be executed in counterparts, all of which shall be considered one and the same document and shall become effective when such counterparts have been signed by each Party and delivered to the other Party, it being understood that all Parties need not sign the same counterpart. Delivery by electronic transmission to counsel for the other Party of a counterpart executed by a Party shall be deemed to meet the requirements of the previous sentence. The exchange of a fully executed Amendment (in counterparts or otherwise) in pdf, docusign or similar format and transmitted by facsimile or email shall be sufficient to bind the Parties to the terms and conditions of this Amendment.

 

5. Effect of This Amendment. This Amendment is made a part of the Agreement. Except as otherwise expressly provided herein, the Agreement is, and shall continue to be, in full force and effect and is hereby ratified and confirmed in all respects, except that on and after the date hereof all references in the Agreement to “this Agreement”, “hereto”, “hereof”, “hereunder” or words of like import referring to the Agreement shall mean the Agreement as amended by this Amendment. Any reference to the Agreement contained in any notice, request, certificate or other document executed concurrently with or after the execution and delivery of this Amendment shall be deemed to refer to the Agreement as modified by this Amendment unless the context shall otherwise require. For the avoidance of doubt, references to the phrases “the date of this Agreement” or “the date hereof”, wherever used in the Agreement, as amended by this Amendment, shall mean August 21, 2024.

 

6. Other Provisions. All other provisions of the Agreement not specifically amended by this Amendment shall remain in full force and effect. Section 9.03 (Binding Effect; Assignment), Section 9.05 (Governing Law), Section 9.06 (Jurisdiction), Section 9.07 (WAIVER OF JURY TRIAL), Section 9.09 (Severability), Section 9.10 (Amendment; Waiver) and Section 9.12 (Interpretation) of the Agreement are incorporated herein by reference and shall apply mutatis mutandis to this Amendment.

 

[Signature Pages Follow]

 

 

IN WITNESS WHEREOF, the Parties have caused this Amendment to be executed as of the date first written above.

 

	The Purchaser:
	INFLECTION POINT ACQUISITION CORP. II
	By:	/s/ Michael Blitzer
	Name:	Michael Blitzer
	Title:	Chairman and Chief Executive Officer

 

[Signature Page to Amendment No. 1 to Business Combination Agreement]

 

 

	The Company:
	USA RARE EARTH, LLC
	By:	/s/ David Kronenfeld
	Name:	David Kronenfeld
	Title:	Chief Legal Officer

 

[Signature Page to Amendment No. 1 to Business Combination Agreement]

 

Exhibit 10.1

 

NON-REDEMPTION AGREEMENT

 

THIS NON-REDEMPTION AGREEMENT (this “Agreement”), dated as of November 13, 2024, is made by and between Inflection Point Acquisition Corp. II, a Cayman Islands exempted company (the “Company”) and the undersigned (the “Holder”).

 

RECITALS

 

WHEREAS, on August 21, 2024, the Company, IPXX Merger Sub, LLC, a Delaware limited liability company and a direct wholly owned subsidiary of the Company (“Merger Sub”) and USA Rare Earth, LLC, a Delaware limited liability company (“USARE”) entered into a business combination agreement (such agreement, as it may be amended, supplemented or otherwise modified from time to time in accordance with its terms, the “Business Combination Agreement” and the transactions contemplated by the Business Combination Agreement, the “Business Combination”), pursuant to which, and subject to the terms and conditions set forth therein, among other things, (i) prior to Closing (as defined below), the Company will domesticate (the “Domestication”) as a Delaware corporation in accordance with the Delaware General Corporation Law and the Companies Act (as Revised) of the Cayman Islands, and (ii) at the closing of the transactions contemplated by the Business Combination Agreement (the “Closing”) and following the Domestication, Merger Sub will merge with and into USARE, with USARE surviving as a wholly-owned subsidiary of the Company, and the Company will be renamed “USA Rare Earth, Inc.” (“New USARE”).

 

WHEREAS, the Company expects to hold an extraordinary general meeting in lieu of an annual meeting of the Company’s shareholders (the “Meeting”), for the purpose of approving, among other things, an amendment to the Company’s Amended and Restated Memorandum and Articles of Association (as amended, the “Articles”) to extend (the “Extension”) the date by which the Company must consummate an initial business combination from November 30, 2024 to August 21, 2025 (the “Extended Date”);

 

WHEREAS, in accordance with the terms of this Agreement, the Holder desires to purchase that number of the Company’s Class A ordinary shares, par value $0.0001 per share (“public shares”), set forth on the signature page hereto (the “Purchase Commitment Shares”), in open market transactions at a price no higher than the Redemption Price (as defined in the Articles), no later than one (1) Business Day (as defined herein) prior to the deadline for public shareholders to exercise their Redemption Rights (the “Redemption Date”) in connection with the Meeting;

 

WHEREAS, in accordance with the terms of the Business Combination Agreement and in connection with the Business Combination, all of the issued and outstanding public shares will convert automatically, on a one-for-one basis, into one (1) share of common stock, par value $0.0001 per share, of New USARE (after the Domestication);

 

WHEREAS, in accordance with the terms of this Agreement, the Holder desires to agree not to exercise any Redemption Rights it may have with respect to its Purchase Commitment Shares under the Articles in connection with the Extension;

 

WHEREAS, at least one day prior to the Domestication, the Company will provide its public shareholders the opportunity to redeem their public shares on the terms and conditions set forth in the Business Combination Agreement and the Company’s governing documents (the “Business Combination Redemption”); and

 

WHEREAS, in consideration of the Holder’s agreement hereunder not to redeem the Purchase Commitment Shares in connection with the Extension, the Company will extend to the Holder the option to execute a forward purchase agreement (the “Forward Purchase Option”) in accordance with the terms set forth in a term sheet attached hereto as Exhibit A (the “Term Sheet”).

 

 

NOW, THEREFORE, in consideration of the foregoing and the mutual acknowledgments, understandings, and agreements contained in this Agreement and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Company and Holder hereby agree as follows:

 

1. Purchase of Public Shares.

 

(a) On the terms and subject to the conditions hereof, the Holder hereby (i) attests that it owns as of the date of this Agreement or otherwise (ii) agrees to purchase, in open market transactions at a price no higher than the Redemption Price, no later than the date that is one (1) Business Day prior to the Redemption Date (the “Purchase Deadline”), the Purchase Commitment Shares. For the purposes of this Agreement, “Business Day” means any day other than a Saturday, Sunday or a day on which commercial banks in New York, New York are required or authorized by law to be closed for business.

 

(b) No later than one (1) Business Day following the Purchase Deadline, the Holder shall deliver to the Company a certificate, signed by the Holder, certifying that it (i) has purchased the Purchase Commitment Shares at a per share price no higher than the Redemption Price or (ii) owned the Purchase Commitment Shares at the date of this Agreement.

 

2. Representations, Warranties, Covenants and Agreements of the Holder. The Holder represents, warrants, covenants and agrees that:

 

(a) The Holder (i) is duly organized, validly existing and in good standing under the laws of its jurisdiction of incorporation or organization, and (ii) has the requisite power and authority to enter into and perform its obligations under this Agreement.

 

(b) This Agreement has been duly authorized and validly executed and delivered by the Holder, and assuming the due authorization, execution and delivery of the same by the Company, this Agreement shall constitute the valid and legally binding obligation of the Holder, enforceable against the Holder in accordance with its terms, except as such enforceability may be limited by bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and similar laws affecting creditors’ rights generally and by the availability of equitable remedies.

 

(c) The execution and delivery of this Agreement, the purchase of the Purchase Commitment Shares and the compliance by the Holder with all of the provisions of this Agreement and the consummation of the transactions contemplated hereby will not conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, or result in the creation or imposition of any lien, charge or encumbrance upon any of the property or assets of the Holder pursuant to the terms of (i) any indenture, mortgage, deed of trust, loan agreement, lease, license or other agreement or instrument to which the Holder is a party or by which the Holder is bound or to which any of the property or assets of the Holder is subject; (ii) the organizational documents of the Holder; or (iii) any statute or any judgment, order, rule or regulation of any court or governmental agency or body, domestic or foreign, having jurisdiction over the Holder or any of its properties that, in the case of clauses (i) and (iii), would reasonably be expected to have a Holder Material Adverse Effect. For purposes of this Agreement, a “Holder Material Adverse Effect” means an event, change, development, occurrence, condition or effect with respect to the Holder that would, individually or in the aggregate, reasonably be expected to have a material adverse effect on the Holder’s ability to timely consummate the transactions contemplated hereby, including the purchase of the Purchase Commitment Shares.

 

(d) The Holder is capable of assessing the merits of and understanding (on its own behalf or through independent professional advice), and understands and accepts, the terms, conditions and risks of this Agreement and the transactions contemplated hereby. The Holder is also capable of assuming, and assumes, the risks of this Agreement and the transactions contemplated hereby, including, if exercised, the Forward Purchase Option. The Holder is a sophisticated investor, experienced in investing in private equity transactions and capable of evaluating investment risks independently, both in general and with regard to all transactions and investment strategies involving a security or securities. The Holder has adequately analyzed and fully considered the risks of this Agreement and the transactions contemplated hereby, including of an investment in the Purchase Commitment Shares, and has determined that the transactions contemplated by this Agreement, including the purchase of the Purchase Commitment Shares, are a suitable for the Holder and that the Holder is able at this time and in the foreseeable future to bear the economic risk of a total loss of its investment in the Company. The Holder acknowledges specifically that a possibility of total loss of its investment exists.

 

 

(e) It is, and at the time it exercises the Forward Purchase Option and at the time it enters into any definitive agreement with respect thereto will be an “eligible contract participant” under, and as defined in, the Commodity Exchange Act (7 U.S.C. § 1a(18)) and CFTC regulations (17 CFR § 1.3).

 

(f) The Holder acknowledges that it is not relying upon, and has not relied upon, any statement, representation or warranty made by any person, firm or corporation (including the Company, New USARE, or USARE, any of their respective affiliates or any of its or their respective control persons, officers, directors, employees, agents or representatives), other than the representations and warranties of the Company expressly set forth in this Agreement, or any other investor in making its investment or decision to invest in the Company.

 

(g) There is no action pending against the Holder or, to the Holder’s knowledge, threatened against the Holder, before any court, arbitrator, or governmental authority, which in any manner challenges or seeks to prevent, or enjoin or materially delay the performance by the Holder of its obligations under this Agreement.

 

(h) The Holder, together with each other person with whom it may form a “group” (within the meaning of Rule 13d-5(b)(1) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), is in compliance with all material regulatory filings relating to this Agreement and the transactions contemplated hereby, including, if exercised, the Forward Purchase Option. The Holder covenants that it will make all regulatory filings that it is required by law or regulation to make with respect to this Agreement and the transactions contemplated hereby, including, if exercised, the Forward Purchase Option, including, without limitation, as may be required by Section 13 or Section 16 under the Exchange Act.

 

(i) The Holder agrees to not vote any public shares it holds as of the applicable record date in connection with the Business Combination at any meeting of the Company’s shareholders (or to provide a written consent for that purpose with respect to such shares) if it would be in violation of the Securities and Exchange Commission’s Compliance and Disclosure Interpretation No. 166.01 to do so.

 

3. Waiver of Redemption Rights.

 

(a) The Holder acknowledges that it has, or will have, certain rights with respect to the redemption of the Holder’s Purchase Commitment Shares pursuant to the Articles and in connection with the consummation of the Extension. Holder covenants and agrees, for the benefit of the Company, that neither it nor any of its controlled affiliates shall exercise any Redemption Rights under the Articles in connection with the consummation of the Extension with respect to the Holder’s Purchase Commitment Shares (the “Redemption Rights”).

 

(b) In furtherance of the covenants in Section 2(a): (x) Holder hereby irrevocably waives, on behalf of itself and its controlled affiliates, the Redemption Rights and irrevocably constitutes and appoints the Company and its designees, with the power of substitution, as its (and its controlled affiliates’) true and lawful agent and attorney-in-fact, with the power and authority in its name, place and stead, to revoke any redemption election made in contravention of Section 2(a) above limited solely with respect to any Holder’s Purchase Commitment Shares and to cause the Company’s transfer agent to fail to redeem such Holder’s Purchase Commitment Shares in connection with the Extension, (y) Holder shall deliver such documentation as is reasonably requested by the Company to evidence that none of the Holder’s Purchase Commitment Shares have been redeemed, and (z) in the event of a breach of Section 2(a) with respect to any Holder’s Purchase Commitment Shares (the “Redeemed Shares”), Holder unconditionally and irrevocably agrees to, or to cause one or more of its affiliates to, subscribe for and purchase from the Company (or from its assignee(s) or designee(s)) prior to the Extended Date a number of public shares of the Company equal to the number of such Redeemed Shares, for a per share purchase price equal to the amount to be received by public shareholders of the Company exercising their Redemption Rights in connection with the Extension.

 

(c) The Company acknowledges and agrees that the Holder and/or its controlled affiliates may own additional public shares in excess of the Holder’s Purchase Commitment Shares (the “Other Shares”) and that nothing herein shall restrict any rights of the Holder with respect to such Other Shares including, without limitation, the right to redeem, or to submit a request to the Company’s transfer agent to redeem or otherwise exercise any right with respect to such Other Shares.

 

 

(d) The Company acknowledges and agrees that nothing herein shall restrict any rights of the Holder with respect to the Business Combination Redemption, including, without limitation, the right to redeem, or to submit a request to the Company’s transfer agent to redeem or otherwise exercise any right with respect to public shares in connection with the Business Combination Redemption.

 

4. Covenants of the Holder. Holder hereby agrees to permit the Company to publish and disclose Holder’s identity, ownership and/or acquisition of the Holder’s Purchase Commitment Shares and any Other Shares and the nature of Holder’s commitments, arrangements and understandings under this Agreement and a copy of this Agreement, in (a) the proxy materials filed by the Company with the United States Securities and Exchange Commission (“SEC”) in connection with the Extension and/or the Company’s initial Business Combination, (b) any Form 8-K filed by the Company with the SEC in connection with the execution and delivery of this Agreement, or the consummation of the Extension or in connection with the Company’s initial business combination, and (c) any other documents or communications provided by the Company or the Company to any governmental authority or to the Holder, in each case, to the extent required by the federal securities laws or the SEC or any other securities authorities. Additionally, the Holder shall not, at any time while this Agreement remains in effect, (i) enter into any agreement or trust with respect to the Purchase Commitment Shares inconsistent with Holder’s obligations pursuant to this Agreement, (ii) grant a proxy, a consent or power of attorney with respect to the Purchase Commitment Shares, or (iii) enter into any agreement or take any action that would make any representation or warranty of the Holder contained herein untrue or inaccurate in any material respect or have the effect of preventing or disabling the Holder from performing any of its obligations under this Agreement.

 

5. Forward Purchase Agreement. In consideration of the covenants of Holder set forth herein, the Company extends to the Holder the Forward Purchase Option to execute a forward purchase agreement with the Company in connection with the Business Combination in accordance with the terms set forth in the Term Sheet. The Forward Purchase Option expires on the Business Day preceding the Business Combination Redemption. The obligations of the Company pursuant to this Section 5 shall be subject to the satisfaction or waiver by the Company of the following conditions: (i) the Extension shall have occurred, (ii) all representations and warranties of the Holder contained in this Agreement shall be true and correct in all material respects (other than representations and warranties that are qualified as to materiality, which representations and warranties shall be true and correct in all respects) as of the date hereof, as of the Purchase Deadline and as of the date of the exercise of the Forward Purchase Option, and (iii) the Holder shall have performed, satisfied and complied in all material respects with all covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by it.

 

6. Miscellaneous.

 

(a) Holder acknowledges that the Company will rely on the representations, warranties, acknowledgments, understandings and agreements contained in this Agreement. Holder agrees to promptly notify the Company if any of the representations, warranties, acknowledgments, understandings or agreements set forth herein are no longer accurate in all material respects.

 

(b) Each of the Company and the Holder is entitled to rely upon this Agreement and is irrevocably authorized to produce this Agreement or a copy hereof to any interested party in any administrative or legal proceeding or official inquiry with respect to the matters covered hereby.

 

(c) Neither this Agreement nor any rights that may accrue to Holder hereunder may be transferred or assigned without the Company’s prior written consent. Neither this Agreement nor any rights that may accrue to the Company hereunder may be transferred or assigned.

 

(d) This Agreement may not be modified, waived or terminated except by an instrument in writing, signed by the party against whom enforcement of such modification, waiver, or termination is sought.

 

(e) This Agreement constitutes the entire agreement, and supersedes all other prior agreements, understandings, representations and warranties, both written and oral, among the parties, with respect to the subject matter hereof.

 

 

(f) Except as otherwise provided herein, this Agreement shall be binding upon, and inure to the benefit of the parties hereto and their heirs, executors, administrators, successors, legal representatives, and permitted assigns, and the agreements, representations, warranties, covenants and acknowledgments contained herein shall be deemed to be made by, and be binding upon, such heirs, executors, administrators, successors, legal representatives and permitted assigns.

 

(g) The Holder acknowledges that the Company has established a trust account containing the proceeds of its initial public offering and from certain private placements (collectively, with interest accrued from time to time thereon, the “Trust Account”). Holder agrees that (i) it has no right, title, interest or claim of any kind in or to any monies held in the Trust Account, and (ii) it shall have no right of set-off or any right, title, interest or claim of any kind (“Claim”) to, or to any monies in, the Trust Account, in each case in connection with this Agreement, and hereby irrevocably waives any Claim to, or to any monies in, the Trust Account that it may have in connection with this Agreement or otherwise; provided, that such release and waiver of Claims shall not include any rights or claims of Holder or any of its controlled affiliates to seek redemption of (x) the Other Shares in connection with the consummation of the Extension or (y) any of the Holder’s public shares in connection with the consummation of the Company’s initial Business Combination. In the event the Holder has any Claim against the Company, the Holder shall pursue such Claim solely against the Company’s assets outside the Trust Account and not against the property or any monies in the Trust Account. The Holder agrees and acknowledges that such waiver is material to this Agreement and has been specifically relied upon by the Company to induce the Company to enter into this Agreement and the Holder further intends and understands such waiver to be valid, binding and enforceable under applicable law. In the event the Holder commences any action or proceeding which seeks, in whole or in part, relief against the funds held in the Trust Account or distributions therefrom or any of the Company’s shareholders, whether in the form of monetary damages or injunctive relief, the Holder shall be obligated to pay to the Company all of its legal fees and costs reasonably incurred in connection with any such action in the event that the Company prevails in such action or proceeding.

 

(h) If any provision of this Agreement shall be invalid, illegal or unenforceable, the validity, legality or enforceability of the remaining provisions of this Agreement shall not in any way be affected or impaired thereby and shall continue in full force and effect.

 

(i) This Agreement may be executed in two (2) or more counterparts (including by electronic means), all of which shall be considered one and the same agreement and shall become effective when signed by each of the parties and delivered to the other parties, it being understood that all parties need not sign the same counterpart.

 

(j) The Holder shall pay all of its own expenses in connection with this Agreement and the transactions contemplated hereby.

 

(k) Any notice or communication required or permitted hereunder shall be in writing and either delivered personally, emailed, sent by overnight mail via a reputable overnight carrier, or sent by certified or registered mail, postage prepaid, and shall be deemed to be given and received (a) when so delivered personally, (b) when sent, with no mail undeliverable or other rejection notice, if sent by email, or (c) five (5) Business Days after the date of mailing to the address below or to such other address or addresses as such person may hereafter designate by notice given hereunder:

 

i. If to Holder, to such address or addresses set forth on the signature page hereto; and

 

ii. if to the Company, to:

 

Inflection Point Acquisition Corp. II

 

167 Madison Avenue, Suite 205 #1017

 

New York, NY 10016

 

Attn: Michael Blitzer

 

 

Email: [***]

 

with a copy to (which copy shall not constitute notice):

 

White & Case LLP

 

1221 Avenue of the Americas

 

New York, New York 10020

 

Attention: Joel Rubinstein

 

Email: joel.rubinstein@whitecase.com

 

(l) The parties agree that irreparable damage for which monetary damages, even if available, would not be an adequate remedy, would occur in the event that the parties do not perform their obligations under the provisions of this Agreement (including failing to take such actions as are required of them hereunder to consummate this Agreement) in accordance with its specified terms or otherwise breach such provisions. The parties acknowledge and agree that (i) the parties shall be entitled to an injunction, specific performance, or other equitable relief, to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof, without proof of damages, this being in addition to any other remedy to which they are entitled under this Agreement, and (ii) the right of specific enforcement is an integral part of the transactions contemplated by this Agreement and without that right, none of the parties would have entered into this Agreement. Each party agrees that it will not oppose the granting of specific performance and other equitable relief on the basis that the other parties have an adequate remedy at law or that an award of specific performance is not an appropriate remedy for any reason at law or equity. The parties acknowledge and agree that any party seeking an injunction to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement in accordance with this Section 6(l) shall not be required to provide any bond or other security in connection with any such injunction.

 

(m) This Agreement, and all claims or causes of action based upon, arising out of, or related to this Agreement or the transactions contemplated hereby, shall be governed by, and construed in accordance with, the laws of the State of Delaware, without giving effect to principles or rules of conflict of laws to the extent such principles or rules would require or permit the application of laws of another jurisdiction

 

(n) Any claim, action, suit, assessment, arbitration or proceeding based upon, arising out of or related to this Agreement, or the transactions contemplated hereby, shall be brought in the State of New York, and each of the parties irrevocably submits to the exclusive jurisdiction of each such court in any such claim, action, suit, assessment, arbitration or proceeding, waives any objection it may now or hereafter have to personal jurisdiction, venue or to convenience of forum, agrees that all claims in respect of such claim, action, suit, assessment, arbitration or proceeding shall be heard and determined only in any such court, and agrees not to bring any claim, action, suit, assessment, arbitration or proceeding arising out of or relating to this Agreement or the transactions contemplated hereby in any other court. Nothing herein contained shall be deemed to affect the right of any party to serve process in any manner permitted by law, or to commence legal proceedings or otherwise proceed against any other party in any other jurisdiction, in each case, to enforce judgments obtained in any claim, action, suit, assessment, arbitration or proceeding brought pursuant to this Section 6(n). EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY ACTION BASED UPON, ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.

 

(o) Nothing contained in this Agreement shall be deemed to vest in the Company or its subsidiaries any direct or indirect ownership or incidence of ownership of or with respect to the Holder’s Purchase Commitment Shares. All rights, ownership and economic benefits of and relating to the Holder’s Purchase Commitment Shares shall remain fully vested in and belong to the Holder, and none of the Company or its subsidiaries shall have no authority to direct the Holder in the voting or disposition of any of the Holder’s Purchase Commitment Shares, except as otherwise provided herein.

 

(p) The Holder hereby agrees that its representations, warranties and covenants set forth herein are solely for the benefit of the Company and its subsidiaries in accordance with and subject to the terms of this Agreement, and this Agreement is not intended to, and does not, confer upon any person other than the parties hereto any rights or remedies hereunder, including the right to rely upon the representations and warranties set forth herein, and the parties hereto hereby further agree that this Agreement may only be enforced against, and any action that may be based upon, arise out of or relate to this Agreement, or the negotiation, execution or performance of this Agreement may only be made against, the persons expressly named as parties hereto.

 

(q) If any provision of this Agreement is held invalid or unenforceable by any court of competent jurisdiction, the other provisions of this Agreement shall remain in full force and effect. The parties further agree that if any provision contained herein is, to any extent, held invalid or unenforceable in any respect under the laws governing this Agreement, they shall take any actions necessary to render the remaining provisions of this Agreement valid and enforceable to the fullest extent permitted by law and, to the extent necessary, shall amend or otherwise modify this Agreement to replace any provision contained herein that is held invalid or unenforceable with a valid and enforceable provision giving effect to the intent of the parties.

 

[Signature Page Follows]

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed as of the date first above written.

 

COMPANY:
INFLECTION POINT ACQUISITION CORP. II
By:	/s/ Michael Blitzer
Name:	Michael Blitzer
Title:	Chief Executive Officer and Chairman
HOLDER:
NEWTYN PARTNERS, LP
NEWTYN TE PARTNERS, LP
By:	/s/ Noah Levy
Name:	Noah Levy
Title:	Managing Member

 

Number of Purchase Commitment Shares to be purchased:

 

Address for Notices: [***]______

 

Attention: _[***]________________________________________

 

 

 

Email: _[***]____________________________________

 

[Signature Page to Share Purchase and Non-Redemption Agreement]

 

 

EXHIBIT A

 

Term Sheet

 

 

60 East 42^nd Street, Suite 950 ● New York, NY 10165 ● (212-) 446-2460

 

Summary of Proposed Terms and Conditions for

Inflection Point Acquisition Corp. II

 

Buyer:	Inflection Point Acquisition Corp. II (the “Company”).  The term “Buyer” refers to IPXX until the Business Combination (as defined below), and to USA Rare Earth, Inc., a Delaware corporation, following the Business Combination.  Upon the closing of the transactions contemplated by the Business Combination Agreement (as defined below), USA Rare Earth, LLC (the “Target”) will be a wholly-owned direct subsidiary of the Company.
Seller:	Newtyn Partners, LP and Newtyn TE Partners, LP or their respective affiliates (collectively, the “Seller”).  The obligations of each Seller shall be several and not joint.
Currency:	US Dollars (“$”).
Investment Terms
Transaction:	Share Forward Transaction (the “Transaction”) of up to 700,000 ordinary shares of the Company  (the “Shares”) in connection with the proposed business combination between the Company and the Target (the “Business Combination”).
Indicative Transaction  Steps:	Condition to Transaction: At least one Exchange Business Day (as defined below) prior to the redemption deadline in connection with the Buyer’s extension of its time to complete an initial business combination (the “Extension”), (a) the Seller will purchase 700,000 ordinary Shares of the Buyer at market price in the public market and (b) waive its redemption rights with respect to such Shares in connection with the Extension.   Step 1: At the Seller’s option, prior to the closing of the Business Combination, the Seller will (a) hold 700,000 Shares, or if necessary, purchase up to 700,000 Shares directly from investors who have redeemed at market price in the public market, (b) waive its redemption rights with respect to such Shares, and (c) enter into legal agreements with the Buyer and Target in order to implement the Transaction.   Step 2: Upon closing of the Business Combination, the Buyer will pay the Prepayment Amount (as defined below) to an escrow account for the benefit of the Seller from the cash held in the Buyer’s trust account. The Prepayment Amount will be invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations.   Step 3: At any time prior to the Maturity Date (as defined below), the Seller may, in its sole discretion, elect an interim cash settlement, in which case the Seller may sell some or all of the Shares and pay the pro-rata portion of any applicable Prepayment Amount to the Buyer in respect of such proceeds from the sale of such Shares. For the avoidance of doubt, in connection with any such interim cash settlement, the Seller shall retain any proceeds in excess of the Prepayment Amount paid to the Buyer and the applicable portion of the Prepayment Amount plus the interest accrued on the applicable portion of the Prepayment Amount shall be released from escrow to the Buyer.   Step 4: At the Maturity Date, with respect to any Shares remaining under the Transaction, the Seller shall return the Shares to the Buyer and the amount remaining in the escrow account, including accrued interest, shall be released to the Seller.

 

 

60 East 42^nd Street, Suite 950 ● New York, NY 10165 ● (212-) 446-2460

 

Pricing Date Notice:	Seller shall deliver to Buyer the Pricing Date Notice no later than one (1) business day in which Nasdaq and commercial banks in the City of New York are open for business (each such day an “Exchange Business Day”) following the closing of the Business Combination.  The Pricing Date Notice shall include the number of Shares subject to this Term Sheet.
Pricing Date:	The date specified in the Pricing Date Notice.
Effective Date:	One (1) Settlement Cycle following the Pricing Date.
Number of Shares:	The number of Shares owned by Seller on the day prior to the close of the Business Combination (such Shares referred to herein as the “Public Shares”), as specified in the Pricing Date Notice, but in no event more than the Maximum Number of Shares (as defined below).  The number of Public Shares is subject to reduction as described under “Optional Early Termination.”
Maximum Number of Shares:	700,000 Shares.
Valuation Date:	The date that is 90 days after the closing of the Business Combination (the “Maturity Date”) pursuant to the Business Combination Agreement, dated as of August 21, 2024 (the “Business Combination Agreement”).
Initial Price:	The redemption price per public share in the redemption in connection with the Business Combination in accordance with the Buyer’s governing documents (the “Redemption Price”).
Prepayment:	Payment of the Prepayment Amount (as defined below) shall be made directly from the Buyer’s Trust Account maintained by Continental Stock Transfer & Trust Company holding the net proceeds of the sale of the units in Buyer’s initial public offering (the “Trust Account”) no later than the Prepayment Date.
Prepayment Amount:	A cash amount equal to the number of Public Shares multiplied by the Initial Price, which amount Buyer will place into an escrow account for the benefit of the Seller upon the closing of the Business Combination.  The Prepayment Amount will be invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations.
Prepayment Date:	The earlier of (a) one (1) Exchange Business Day after the closing of the Business Combination and (b) the date any assets from the Trust Account are disbursed following the Business Combination.
Representations, Warranties and Covenants:	Representations and warranties shall be typical for a transaction of this type and size with such exceptions as the parties mutually agree.
Events of Default:	Events of Default shall be typical for a transaction of this type and size.
Optional Early Termination:	From time to time and on any Exchange Business Day following the closing of the Business Combination (any such date, an “OET Date”), and subject to the terms and conditions below, Seller may, in its absolute discretion, terminate the Transaction in whole or in part with respect to any number of Public Shares by giving notice of such termination and the specified number of Shares (such quantity, the “Terminated Shares”). As of each OET Date, Buyer shall be entitled to an amount from Seller, and the Seller shall pay to Buyer from the escrow account, an amount equal to the product of (i) the quotient of (a) the Terminated Shares divided by (b) the Public Shares, multiplied by (ii) the value of the escrow account at such OET Date.  For example, if the Seller terminates with respect to 50% of the Public Shares as of an OET Date, 50% of value of the escrow account as of such OET Date will be released to the Buyer.
Governing Law/Venue:	New York law (without reference to choice of law doctrine).

 

(The remainder of this page intentionally left blank)

 

 

60 East 42^nd Street, Suite 950 ● New York, NY 10165 ● (212-) 446-2460

 

By:	Newtyn Partners, LP		By:	Newtyn TE Partners, LP		By:	Inflection Point Acquisition Corp. II
/s/ Noah Levy			/s/ Noah Levy			/s/ Michael Blitzer
Name:	Noah Levy		Name:	Noah Levy		Name:	Michael Blitzer
Title:	Managing Member		Title:	Managing Member		Title:	Chief Executive Officer and Chairman

 

 

 

 

v3.24.3

Cover	Nov. 12, 2024
Document Type	8-K
Amendment Flag	false
Document Period End Date	Nov. 12, 2024
Entity File Number	001-41711
Entity Registrant Name	Inflection Point Acquisition Corp. II
Entity Central Index Key	0001970622
Entity Tax Identification Number	00-0000000
Entity Incorporation, State or Country Code	E9
Entity Address, Address Line One	167 Madison Avenue Suite 205 #1017
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10016
City Area Code	(212)
Local Phone Number	476-6908
Written Communications	true
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one redeemable warrant
Title of 12(b) Security	Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one redeemable warrant
Trading Symbol	IPXXU
Security Exchange Name	NASDAQ
Class A ordinary shares, par value $0.0001 per share
Title of 12(b) Security	Class A ordinary shares, par value $0.0001 per share
Trading Symbol	IPXX
Security Exchange Name	NASDAQ
Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
Title of 12(b) Security	Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
Trading Symbol	IPXXW
Security Exchange Name	NASDAQ

---